A new method for measuring eosinophil activating factors, based on the increased expression of CR3 α chain (CD11b) on the surface of activated eosinophils
- 1 October 1990
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 133 (1) , 47-54
- https://doi.org/10.1016/0022-1759(90)90317-o
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Hypodense eosinophils in allergic rhinitisJournal of Allergy and Clinical Immunology, 1988
- Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.Journal of Clinical Investigation, 1988
- The presence of hypodense eosinophils and diminished chemiluminescence response in asthmaJournal of Allergy and Clinical Immunology, 1988
- Recombinant human interleukin 5 is a selective activator of human eosinophil function.The Journal of Experimental Medicine, 1988
- Leukotriene C4 production by normal-density and low-density eosinophils of atopic individuals and other patients with eosinophilia1Journal of Allergy and Clinical Immunology, 1987
- Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival.Journal of Clinical Investigation, 1986
- Enhanced eosinophil luminol-dependent chemiluminescence in allergic rhinitisJournal of Allergy and Clinical Immunology, 1986
- A comparison of eosinophil-activating factor (EAF) with other monokines and lymphokinesEuropean Journal of Immunology, 1986
- Partial purification and biological properties of an eosinophil-activating factorEuropean Journal of Immunology, 1985
- Enhanced Helminthotoxic Capacity of Eosinophils from Patients with EosinophiliaNew England Journal of Medicine, 1980